Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 1,244		$ 20,333,548	$ (23,277,851)	$ (2,943,059)
Balance, shares at Dec. 31, 2019	12,444,165
Stock based compensation			351,895		351,895
Series A preferred stock accretion			(250,000)		(250,000)
Series B preferred stock issued for cash, net of issuance costs		$ 189,515			189,515
Series B preferred stock issued for cash, net of issuance costs, shares		15,299
Series B preferred stock issued in exchange for convertible debt		$ 2,737,061			2,737,061
Series B preferred stock issued in exchange for convertible debt, shares		182,449
Common Stock issued for to consultants for services	$ 3		187,497		187,500
Common Stock issued for to consultants for services, shares	25,000
Conversion of convertible debt to Common Stock	$ 11		796,058		796,069
Conversion of convertible debt to Common Stock, shares	106,142
Net loss				(2,580,567)	(2,580,567)
Ending balance, value at Mar. 31, 2020	$ 1,258	$ 2,926,576	21,418,998	(25,858,418)	(1,511,586)
Balance, shares at Mar. 31, 2020	12,575,307	197,748
Beginning balance, value at Dec. 31, 2019	$ 1,244		20,333,548	(23,277,851)	$ (2,943,059)
Balance, shares at Dec. 31, 2019	12,444,165
Exercise of stock options, shares
Conversion of convertible debt to Common Stock, shares					106,314
Net loss					$ (5,807,407)
Ending balance, value at Sep. 30, 2020	$ 1,261	$ 4,979,625	22,178,030	(29,085,258)	(1,926,342)
Balance, shares at Sep. 30, 2020	12,610,813	335,297
Beginning balance, value at Mar. 31, 2020	$ 1,258	$ 2,926,576	21,418,998	(25,858,418)	(1,511,586)
Balance, shares at Mar. 31, 2020	12,575,307	197,748
Stock based compensation			565,372		565,372
Series A preferred stock accretion			(250,000)		(250,000)
Series B preferred stock issued for cash, net of issuance costs		$ 40,168			40,168
Series B preferred stock issued for cash, net of issuance costs, shares		3,333
Series B preferred stock issued in exchange for convertible debt		$ 115,140			115,140
Series B preferred stock issued in exchange for convertible debt, shares		7,674
Common Stock issued for to consultants for services	$ 3		249,998		250,001
Common Stock issued for to consultants for services, shares	33,334
Conversion of convertible debt to Common Stock
Conversion of convertible debt to Common Stock, shares	172
Net loss				(1,413,672)	(1,413,672)
Ending balance, value at Jun. 30, 2020	$ 1,261	$ 3,081,884	21,984,368	(27,272,090)	(2,204,577)
Balance, shares at Jun. 30, 2020	12,608,813	208,755
Stock based compensation			428,662		$ 428,662
Exercise of stock options, shares					200,000
Series A preferred stock accretion			(250,000)		$ (250,000)
Series B preferred stock issued for cash, net of issuance costs		$ 1,822,985			1,822,985
Series B preferred stock issued for cash, net of issuance costs, shares		121,535
Series B preferred stock issued in exchange for convertible debt		$ 74,756			74,756
Series B preferred stock issued in exchange for convertible debt, shares		5,007
Common Stock issued for to consultants for services			15,000		15,000
Common Stock issued for to consultants for services, shares	2,000
Conversion of convertible debt to Common Stock
Net loss				(1,813,168)	(1,813,168)
Ending balance, value at Sep. 30, 2020	$ 1,261	$ 4,979,625	22,178,030	(29,085,258)	(1,926,342)
Balance, shares at Sep. 30, 2020	12,610,813	335,297
Beginning balance, value at Dec. 31, 2020	$ 1,821		52,250,266	(35,334,728)	16,917,359
Balance, shares at Dec. 31, 2020	18,209,452
Stock based compensation			434,291		434,291
Common Stock issued for to consultants for services	$ 1		19,999		20,000
Common Stock issued for to consultants for services, shares	2,667
Warrants issued to consultants for services			231,715		231,715
Warrants issued in asset purchase			136,326		136,326
Net loss				(3,399,242)	(3,399,242)
Ending balance, value at Mar. 31, 2021	$ 1,822		53,072,597	(38,733,970)	14,340,449
Balance, shares at Mar. 31, 2021	18,212,119
Beginning balance, value at Dec. 31, 2020	$ 1,821		52,250,266	(35,334,728)	$ 16,917,359
Balance, shares at Dec. 31, 2020	18,209,452
Exercise of stock options, shares					200,000
Net loss					$ (12,895,044)
Ending balance, value at Sep. 30, 2021	$ 2,302		80,696,658	(48,229,771)	32,469,189
Balance, shares at Sep. 30, 2021	23,012,119
Beginning balance, value at Mar. 31, 2021	$ 1,822		53,072,597	(38,733,970)	14,340,449
Balance, shares at Mar. 31, 2021	18,212,119
Stock based compensation			648,053		648,053
Issuance of Common Stock in follow-on public offering, net of issuance costs	460		25,361,974		25,362,434
Issuance of Common Stock in follow-on public offering, net of issuance costs, shares	4,600,000
Warrants issued in business combination			171,689		171,689
Net loss				(4,042,529)	(4,042,529)
Ending balance, value at Jun. 30, 2021	$ 2,282		79,254,313	(42,776,499)	36,480,096
Balance, shares at Jun. 30, 2021	22,812,119
Stock based compensation			1,112,365		1,112,365
Exercise of stock options	$ 20		329,980		330,000
Exercise of stock options, shares	200,000
Net loss				(5,453,272)	(5,453,272)
Ending balance, value at Sep. 30, 2021	$ 2,302		$ 80,696,658	$ (48,229,771)	$ 32,469,189
Balance, shares at Sep. 30, 2021	23,012,119